Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
NCT07333183Phase 2Recruiting
- Sponsor
- Pulmovant
- Start
- Dec 2025
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of mosliciguat in pulmonary hypertension (PH), sponsored by Pulmovant. Started Dec 2025; status: recruiting.
02
Drugs
mosliciguat
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT07333183.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07333183.